Image Ben Hargreaves R&D LNPs: The unknown enabler behind mRNA vaccines Drug delivery technologies are crucial to allow drugs to reach their full potential, and yet they rarely receive much spotlight. Sales & Marketing Is the pharma industry particularly vulnerable to inflation? The pharma industry is often thought of as one that does not struggle in difficult economic periods – even when times are hard, everyone still values their health. Oncology The gut microbiome: the next breakthrough in cancer? Ben Hargreaves discovers how research has emerged outlining how the gut microbiome plays a crucial role in patients’ response to cancer treatments. Market Access Capping the cost of insulin: altruistic or strategic? The price of insulin has become one of the most talked about issues across the pharma industry. Load more results
R&D LNPs: The unknown enabler behind mRNA vaccines Drug delivery technologies are crucial to allow drugs to reach their full potential, and yet they rarely receive much spotlight.
Sales & Marketing Is the pharma industry particularly vulnerable to inflation? The pharma industry is often thought of as one that does not struggle in difficult economic periods – even when times are hard, everyone still values their health.
Oncology The gut microbiome: the next breakthrough in cancer? Ben Hargreaves discovers how research has emerged outlining how the gut microbiome plays a crucial role in patients’ response to cancer treatments.
Market Access Capping the cost of insulin: altruistic or strategic? The price of insulin has become one of the most talked about issues across the pharma industry.
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
